Annovis Bio (ANVS)

Annovis Bio (ANVS) Financial Statements


Annovis Bio Financial Overview

Annovis Bio's market cap is currently ―. The company's EPS TTM is $-5.13; its P/E ratio is -1.17; Annovis Bio is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -14.86M$ -9.54M$ -9.74M$ -3.17M$ -7.67M
EBITDA$ -14.86M$ -9.54M$ -9.74M$ -3.17M$ -7.67M
Net Income Common Stockholders$ -14.72M$ -9.54M$ -9.74M$ -3.09M$ -7.62M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.35M$ 15.72M$ 16.76M$ 28.38M$ 31.99M
Total Assets$ 10.22M$ 22.82M$ 25.55M$ 36.02M$ 32.49M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -6.35M$ -15.72M$ -16.76M$ -28.38M$ -31.99M
Total Liabilities$ 3.56M$ 2.07M$ 5.41M$ 7.70M$ 2.53M
Stockholders Equity$ 6.66M$ 20.74M$ 20.14M$ 28.32M$ 29.96M
Cash Flow-
Free Cash Flow$ -9.37M$ -9.61M$ -11.63M$ -3.61M$ -3.99M
Operating Cash Flow$ -9.37M$ -9.61M$ -11.63M$ -3.61M$ -3.99M
Investing Cash Flow-----
Financing Cash Flow-$ 8.57M$ 7.39K-$ 0.00
Currency in USD

Annovis Bio Earnings and Revenue History

Annovis Bio Debt to Assets

Annovis Bio Cash Flow

Annovis Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis